Ethyl Acetate → HCID 12991195, compound
Reaction equation
C(OCC)(=O)C.C(OC([N:14]1[CH2:19][CH2:18][N:17]([C:20]2[C:21](=[O:40])[N:22]([CH2:38][CH3:39])[C:23]3[C:28]([C:29]=2[C:30]2[CH:35]=[CH:34][CH:33]=[C:32]([Cl:36])[CH:31]=2)=[CH:27][CH:26]=[C:25]([CH3:37])[N:24]=3)[CH2:16][CH2:15]1)=O)(C)(C)C.C(OCC)(=O)C.Cl.[OH-].[Na+]>O>[Cl:36][C:32]1[CH:31]=[C:30]([C:29]2[C:28]3[C:23](=[N:24][C:25]([CH3:37])=[CH:26][CH:27]=3)[N:22]([CH2:38][CH3:39])[C:21](=[O:40])[C:20]=2[N:17]2[CH2:16][CH2:15][NH:14][CH2:19][CH2:18]2)[CH:35]=[CH:34][CH:33]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a 10 ml ethyl acetate solution containing 570 mg of 3-(1-tert-butoxycarbonylpiperazin-4-yl)-4-(3-chlorophenyl)-1-ethyl-7-methyl-1,8-naphthyridin-2(1H)-one was added a 10 ml 4M hydrogen chloride-ethyl acetate solution, followed by stirring at room temperature for 1 hour. After adding water, the reaction mixture was neutralized with 1M sodium hydroxide aqueous solution, and then extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was evaporated and the residue was purified by a silica gel column chromatography (chloroform-methanol-aqueous ammonia) and then recrystallized from diisopropyl ether to obtain 115 mg of 4-(3-chlorophenyl)-1-ethyl-7-methyl-3-(piperazin-1-yl)-1,8-naphthyridin-2(1H)-one as pale yellow crystals.
Workup
- extractionextracted with ethyl acetate
- washThe organic layer was washed with saturated brine
- dry with materialdried over anhydrous magnesium sulfate
- customThe solvent was evaporated
- customthe residue was purified by a silica gel column chromatography (chloroform-methanol-aqueous ammonia)
- customrecrystallized from diisopropyl ether
Sources & evidence
- ORD record
- ord-2d193f31159547dfb1cd6a9cc5c63a6e
- Source dataset
- uspto-grants-2004_05
- Patent number
- US06740662B1
Reaction notes
Loading…